Ikarian Capital, LLC Tg Therapeutics, Inc. Put Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$15.48 - $35.0 $12.8 Million - $28.9 Million
826,100 New
826,100 $20.5 Million
Q3 2021

Nov 15, 2021
SELL
$21.78 - $40.45 $30,492 - $56,630
-1,400 Reduced 1.4%
98,600 $3.28 Million
Q4 2020

Feb 12, 2021
BUY
$25.27 - $54.9 $2.53 Million - $5.49 Million
100,000 New
100,000 $5.2 Million

Others Institutions Holding TGTX

# of Institutions
336
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email